Author: Michael

Dwayne Johnson, Kevin Hart, Jack Black, and Karen Gillan reunite in ‘Jumanji: Open World,’ the final installment of the globally beloved action-adventure trilogy. Our heroes have escaped the perilous jungles before, but this time ‘Jumanji’ breaks free of its console, unleashing its chaos into our world. ‘Jumanji: Open World’ is in theaters on Dec. 25. More from Entertainment Tonight: https://www.youtube.com/channel/UCdtXPiqI2cLorKaPrfpKc4g?sub_confirmation=1 Exclusives from #EntertainmentTonight : https://www.youtube.com/playlist?list=PLQwITQ__CeH2Y_7g2xeiNDa0vQsROQQgv

Read More

Elon Musk is criticizing Anne Hathaway for a 2018 speech she gave in support of the gay and trans community. “She’s just a marionette. Whoever wrote her speech is the real douchebag,” Musk, 55, wrote via X on Sunday, July 26, in response to marketing professor Gad Saad’s brutal critique of Hathaway speaking at the Human Rights Campaign National Dinner in Washington, D.C., nearly eight years ago. The Odyssey star, 43, appeared at the September 2018 event to accept the organization’s National Ally for Equality award, speaking to the crowd about her societal role and greater surroundings. “With the exception…

Read More

After seven years, Sony’s “Jumanji” reboot series is returning to theaters this Christmas with “Jumanji: Open World,” which released its first trailer on Tuesday. At the end of the 2019 film “Jumanji: The Next Level,” the four former high school classmates who got sucked into the magical “Jumanji” video game were shocked to find that the creatures inside the game had somehow broken out into the real world. But as we see in the new trailer, the animals are not the only ones that got out. The four video game avatars played by Dwayne Johnson, Jack Black, Kevin Hart and…

Read More

Interest in testosterone replacement therapy keeps climbing, and the TRAVERSE trial remains the largest randomized test of its cardiovascular safety. Here is what men considering treatment and their doctors need to know about the findings. What Is the TRAVERSE Trial and Why Does It Matter? The TRAVERSE trial is the largest randomized controlled study designed to test whether testosterone replacement therapy raises the risk of major heart problems in men with confirmed hypogonadism. Results were published in 2023 in the New England Journal of Medicine. Researchers enrolled 5,246 men ages 45 to 80 who had preexisting cardiovascular disease or a…

Read More